Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1256935
Max Phase: Preclinical
Molecular Formula: C10H11ClN5Na4O13P3
Molecular Weight: 541.63
Molecule Type: Small molecule
Associated Items:
ID: ALA1256935
Max Phase: Preclinical
Molecular Formula: C10H11ClN5Na4O13P3
Molecular Weight: 541.63
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 2-Chloroadenosine Triphosphate Tetrasodium
Synonyms from Alternative Forms(1):
Canonical SMILES: Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C10H15ClN5O13P3.4Na/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21;;;;/h2-3,5-6,9,17-18H,1H2,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21);;;;/q;4*+1/p-4/t3-,5-,6-,9-;;;;/m1..../s1
Standard InChI Key: JGKMWMQAWOVZHJ-ZVQJTLEUSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 541.63 | Molecular Weight (Monoisotopic): 540.9568 | AlogP: -0.98 | #Rotatable Bonds: 8 |
Polar Surface Area: 279.13 | Molecular Species: ACID | HBA: 14 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.87 | CX Basic pKa: 2.03 | CX LogP: -3.65 | CX LogD: -9.56 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.16 | Np Likeness Score: 1.16 |
1. Nahum V, Zündorf G, Lévesque SA, Beaudoin AR, Reiser G, Fischer B.. (2002) Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists., 45 (24): [PMID:12431066] [10.1021/jm020251d] |
2. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
Source(1):